Phenotype: increased circulating fructosamine level

Definition increase in the concentration in the blood of total non enzymatic glycated proteins in the blood

Synonyms
  • increased circulating GSP level
  • increased circulating GSP level
  • increased circulating glycated serum protein level
  • increased circulating glycated serum protein level

MP browserMP:0010087

Login to register interest

Phenotype associations stats

0.85% of tested genes with null mutations on a B6N genetic background have a phenotype association to increased circulating fructosamine level (17/1996)

0.84% females (16/1915) 0.57% males (11/1933)

Select a parameter    



Gene variants with increased circulating fructosamine level

Total number of significant genotype-phenotype associations: 27

Gene / Allele Zygosity Sex Life Stage Phenotype Procedure | Parameter Phenotyping Center | Source P Value Data
Duoxa2
Duoxa2tm1b(KOMP)Wtsi
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 7.0E-24
Fam53b
Fam53btm1b(EUCOMM)Hmgu
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine HMGU | IMPC 4.85E-11
Gck
Gckem1(IMPC)H
HET Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 8.93E-11
Lepr
Leprtm1b(EUCOMM)Wtsi
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 3.38E-9
Plekhg1
Plekhg1tm1a(EUCOMM)Wtsi
HOM Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | EuroPhenome 1.34E-7
Akap9
Akap9tm1a(KOMP)Wtsi
HET Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | EuroPhenome 2.07E-7
Dhdds
Dhddstm1b(KOMP)Wtsi
HET Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine HMGU | IMPC 4.1E-7
Galnt18
Galnt18tm1b(KOMP)Wtsi
HOM Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.15E-6
Rab5c
Rab5ctm1a(EUCOMM)Wtsi
HET Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 3.79E-6
Smim1
Smim1em1(IMPC)Wtsi
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.5E-5
Sirt4
Sirt4tm1b(EUCOMM)Hmgu
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine MRC Harwell | IMPC 1.85E-5
Ptprd
Ptprdtm1b(EUCOMM)Wtsi
HOM Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 1.89E-5
Cyb561
Cyb561tm1a(EUCOMM)Wtsi
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | EuroPhenome 2.13E-5
F730043M19Rik
F730043M19Riktm1b(NCC)WCS
HOM Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 2.26E-5
Serpinb9b
Serpinb9bem1(IMPC)Wtsi
HOM Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 2.4E-5
Arrdc5
Arrdc5tm1b(EUCOMM)Wtsi
HOM Female Male postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | IMPC 4.32E-5
Pex3
Pex3tm1a(EUCOMM)Wtsi
HOM Female postnatal increased circulating fructosamine level Clinical Chemistry | Fructosamine WTSI | EuroPhenome 8.37E-5

Download data as: TSV XLS